Combination therapy with a <scp><i>T</i></scp><i>mprss6</i><scp>RNA</scp>i‐therapeutic and the oral iron chelator deferiprone additively diminishes secondary iron overload in a mouse model of β‐thalassemia intermedia
American journal of hematology